Virtual Incision garners $46M after mini-robot makes surgical debut
With a device weighing only two pounds, the company’s MIRA platform aims to shrink down the surgeon and place them inside the abdomen.
Freenome, Siemens join forces to develop blood test for breast cancer
The humble mammogram may soon be getting a complementary new partner to boost breast cancer screening.
Aclaris’ experimental rheumatoid arthritis drug bolsters chemo in pancreatic cancer models
Scientists at Washington University discovered that by inhibiting a molecule called MK2, Aclaris Therapeutics’ experimental rheumatoid arthritis drug boosted the ability of chemo to kill pancreatic…
FDA turns down BeyondSpring chemo complication drug, asks for another trial
BeyondSpring Pharmaceuticals said the FDA wants another clinical trial to demonstrate patient benefit for its drug, a small molecule developed to treat a dangerous and life-threatening complication of…
Who’s fierce in medtech? Submit your nominations now for 2021’s Fierce 15
As we begin to enter the third year of the COVID-19 pandemic (yes, the third), there’s still work to be done and evermore opportunities for medtech companies to make substantial differences in every…
Curie Therapeutics unveils $75M to widen scope of radiopharmaceuticals for cancer
Radiopharmaceuticals deploy radiation to damage cancer DNA, but Curie Therapeutics sees these therapies opening the door to a wider range of ways to kill tumors. The startup has raised $75 million in…
As CMS drives cost and quality improvements, here’s why glucose management is the newest focus
The focus on glycemic management as a key indicator of patient safety was announced as part of CMS’s annual adjustment to inpatient payment policies, which are accompanied by updated rules for its…
Dr. Jordan Messler, Author at MedCity News
Dr. Jordan Messler Jordan Messler, MD, SFHM, FACP is chief medical officer at Glytec, and has led national quality improvement and patient safety initiatives for diabetes management. He trained in internal medicine at Emory University in Atlanta, and subsequently served as an academic hospitalist at Emory University for several years after residency. He is the …
Conservative justices appear poised to overturn Roe’s abortion rights
Judging from the questions asked by the justices, it appeared possible — even likely — that a majority of them could vote to turn the thorny question of whether to allow abortion and under what…
New private equity investment makes Iodine Software the latest healthcare unicorn
Advent International, a private equity firm, is investing an undisclosed amount into Iodine boosting its valuation beyond $1 billion. The hope is that the company’s AI-powered clinical documentation…